Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$33,776 Mln
P/E Ratio
38.92
P/B Ratio
21.17
Industry P/E
--
Debt to Equity
0.17
ROE
0.58 %
ROCE
40.24 %
Div. Yield
0 %
Book Value
19.22
EPS
10.7
CFO
$4,872.40 Mln
EBITDA
$6,702.20 Mln
Net Profit
$4,514.68 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
IDEXX Laboratories (IDXX)
| 1.70 | -5.41 | -1.55 | -20.63 | -7.26 | 14.26 | 18.68 |
|
BSE Sensex
| -3.77 | -0.92 | -6.67 | 3.66 | 9.18 | 19.75 | 10.11 |
|
S&P Midcap 400
| -5.36 | -7.78 | -8.87 | 0.89 | 3.19 | 16.02 | 6.92 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
IDEXX Laboratories (IDXX)
| -25.33 | 36.06 | -38.04 | 31.73 | 91.43 | 40.38 | 18.84 |
|
S&P Midcap 400
| 12.12 | 14.45 | -14.48 | 23.21 | 11.81 | 24.05 | -12.43 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 231.60 | 64,886.77 | 38.04 | 6.76 | |
| 70.14 | 40,735.59 | 29.61 | 50.15 | |
| 219.65 | 32,921.71 | 26.47 | 24.69 | |
| 236.36 | 36,983.33 | 52.73 | 12.96 |
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three... segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine. Address: One IDEXX Drive, Westbrook, ME, United States, 04092 Read more
President, CEO & Director
Mr. Jonathan J. Mazelsky
President, CEO & Director
Mr. Jonathan J. Mazelsky
Headquarters
Westbrook, ME
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of IDEXX Laboratories Inc (IDXX) stood at $ 3,293 Mln as on 31-Dec-24
The share price of IDEXX Laboratories Inc (IDXX) is $420.46 (NASDAQ) as of 18-Mar-2025 14:37 EDT. IDEXX Laboratories Inc (IDXX) has given a return of -7.26% in the last 3 years.
IDEXX Laboratories Inc (IDXX) has a market capitalisation of $ 33,776 Mln as on 17-Mar-2025. As per Value Research classification, it is a Mid Cap company.
The P/E ratio of IDEXX Laboratories Inc (IDXX) is 38.92 times as on 17-Mar-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the IDEXX Laboratories Inc (IDXX) and enter the required number of quantities and click on buy to purchase the shares of IDEXX Laboratories Inc (IDXX).
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine. Address: One IDEXX Drive, Westbrook, ME, United States, 04092
The CEO & director of Mr. Jonathan J. Mazelsky. is IDEXX Laboratories Inc (IDXX), and CFO & Sr. VP is Mr. Jonathan J. Mazelsky.
There is no promoter pledging in IDEXX Laboratories Inc (IDXX).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
6,440
|
|
|
4,283
|
|
|
3,571
|
|
|
3,287
|
| IDEXX Laboratories Inc. (IDXX) | Ratios |
|---|---|
|
Return on equity(%)
|
57.66
|
|
Operating margin(%)
|
29.28
|
|
Net Margin(%)
|
22.78
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of IDEXX Laboratories Inc (IDXX) was $888 Mln.
$-1.90
(
